HAMILTON, Bermuda I May 27, 2025 I Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and ...

Former President Joe Biden was diagnosed with an "aggressive form" of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president's prostate cancer is ...

This dynamic interplay has positioned the circRNA-RBP network as a promising target for developing innovative cancer therapies. CircRNAs are unique RNA molecules formed through a back-splicing ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

The global circRNA synthesis market was valued at USD 184.32 million in 2024 and is projected to Surpass USD 805.44 million by 2034, registering a CAGR of 15.89% from 2025 to 2034. The global circRNA ...

Due to its function as a microRNA sponge, circRNA has gained significant attention as an essential biomarker and potential drug target in the pathogenesis of several cancers. Although many circRNAs ...

a demonstration of CircRNA’s promise. Circio’s pipeline is initially targeting cancer, with plans to expand into vaccines and gene therapy. It wants to create a novel class of targeted, ...

This is the first reported association between circRNA and alternative splicing. The work was published in PNAS. GC is the fifth most common malignant tumor and the third leading cause of cancer ...

The aim of this study was to explore the circRNA relationship between AD and cancer. Materials and Methods: In this investigation, circRNAs that were significantly dysregulated in AD or associated ...